Ex­clu­sive: Cell ther­a­py CD­MO Kin­cell launch­es, and the spin­out is val­ued at $66M, with CEO look­ing for carve-outs

A small CD­MO called Kin­cell Bio launched Wednes­day, with its CEO hop­ing to fill a niche of­fer­ing cell ther­a­py man­u­fac­tur­ing for ear­ly-stage biotech star­tups.

Kin­cell is a spin­out of a Gainesville, FL-based man­u­fac­tur­ing plant of In­cep­tor Bio, a North Car­oli­na cell ther­a­py biotech found­ed in 2020. It’s raised $36 mil­lion in a Se­ries A fi­nanc­ing led by Ki­neti­cos Ven­tures, which val­ues the start­up at $66 mil­lion, a source fa­mil­iar with the mat­ter told End­points News.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER